Medical Device | January 10, 2022
Mylab’s CoviSelf can detect Omicron: Study
Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully
Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully
Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days
The QuickVue antigen tests are able to detect the live Omicron variant with similar performance as with other variants
The TaqMan SARS CoV-2 Mutation Panel is compatible with real-time PCR instruments already commonly used in laboratories around the world
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Subscribe To Our Newsletter & Stay Updated
